Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.85
-0.22-5.41%
At close: -
$4.10
0.256.49%
After Hours: Jul 18, 4:32 PM EDT
Comments
Loading...
Karyopharm Therapeutics Stock Price, Quotes and Forecasts
KPTINASDAQ
Karyopharm Therapeutics (KPTI) Forecast
NewsEarningsKaryopharm Therapeutics (KPTI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Karyopharm Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:KPTI | Benzinga
Explore Karyopharm Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KPTI.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Karyopharm Therapeutics (KPTI) stock?
You can purchase shares of Karyopharm Therapeutics (NASDAQ:KPTI) through any online brokerage.
Who are Karyopharm Therapeutics (KPTI) competitors?
Other companies in Karyopharm Therapeutics’s space includes: Kalaris Therapeutics (NASDAQ:KLRS), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Coeptis Therapeutics (NASDAQ:COEP) and PepGen (NASDAQ:PEPG).
What is the forecast, or price target, for Karyopharm Therapeutics (KPTI) stock?
Karyopharm Therapeutics has a consensus price target of $17.80.
What is the current price for Karyopharm Therapeutics (KPTI)?
The stock price for Karyopharm Therapeutics (NASDAQ: KPTI) is $4.1 last updated July 18, 2025 at 4:32 PM EDT.
Does Karyopharm Therapeutics (KPTI) pay a dividend?
There are no upcoming dividends for Karyopharm Therapeutics.
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics’s Q2 earnings are confirmed for Tuesday, August 5, 2025.
Is Karyopharm Therapeutics (KPTI) going to split?
There is no upcoming split for Karyopharm Therapeutics.
What sector and industry does Karyopharm Therapeutics (KPTI) operate in?
Karyopharm Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
